Law Firm Investigates Option Care Health Amid M&A Concerns
Monteverde & Associates has launched an investigation into Option Care Health (OPCH), a move that could signal potential shareholder claims.
A New York-based securities law firm has announced an investigation into Option Care Health, Inc., the Nasdaq-listed home infusion therapy company trading under the ticker OPCH, according to a statement released October 11, 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, disclosed the probe without specifying the precise nature of the allegations, a common early-stage practice in shareholder litigation. The firm described itself as a ranked Top 50 firm in the 2025 ISS Securities Class Action Services Report and noted it has recovered millions of dollars on behalf of investors in prior cases.
Read more Retail Investing Platforms Hit 41M Accounts Amid Record Growth →
Shareholder investigations of this type frequently precede formal class action lawsuits and typically center on whether a company's board fulfilled its fiduciary duties — particularly in the context of mergers, acquisitions, or other major corporate transactions. The reference to the firm's identity as the "M&A Class Action Firm" suggests the inquiry may relate to a pending or recently completed deal involving Option Care Health, though no transaction details were provided in the announcement.
Investors who hold or recently held shares of OPCH are generally encouraged by such firms to contact counsel to assess potential legal options before any court-imposed deadlines. No lawsuit has been confirmed filed at this stage, and Option Care Health had not issued a public response as of the announcement date.
Continue reading at All Financial Services & Investing.
